Fish Protein Hydrolysate (FPH) Market Size, Share, Growth, and Industry Analysis, By Type (High Purity,Low Purity), By Application (Food,Feed Industry,Pharmaceuticals,Cosmetic,Others), Regional Insights and Forecast to 2033

Fish Protein Hydrolysate (FPH) Market Overview

The Fish Protein Hydrolysate (FPH) Market size was valued at USD 251.94 million in 2024 and is expected to reach USD 337.94 million by 2033, growing at a CAGR of 3.3% from 2025 to 2033.

The global Fish Protein Hydrolysate (FPH) market processed approximately 329.2 million USD worth of products in 2024, with a total output volume around 320 million metric tons documented in the same year. FPH is derived from enzymatic, acid, or autolytic hydrolysis of fish by-products—specifically heads, bones, skins, and frames—where enzymatic technology comprised 84% of market share in 2023 within the technological segment. Powdered FPH dominated with an estimated 68–90% share of form-based applications in 2023–2024.

Applications span animal feed (notably aquaculture), food & beverage, pharmaceuticals, cosmetics, and agriculture; among these, animal feed and pet food accounted for roughly 60% of usage in 2022–2023. Regionally, Asia-Pacific—led by China, India, and Japan—comprised approximately 185 million USD in 2023, while Europe reached about 117 million USD in 2023. The U.S. segment alone represented 50.7 million USD in 2024. Global fish production totaled 182 million tons in 2021, with by-products from aquaculture and capture fisheries providing an estimated 33.8 million tons exploitable for hydrolysate production.

Key Findings

Driver: Increasing demand for sustainable, high-protein feed ingredients in aquaculture and pet nutrition is the leading driver. In 2023, over 60% of FPH output was consumed by the animal feed sector, especially in aquafeed.

Top Country/Region: Asia-Pacific remains the dominant region in the FPH market, accounting for over 55% of global consumption in 2023, led by high aquaculture production in China, India, and Vietnam.

Top Segment: By form, powdered fish protein hydrolysate accounted for approximately 68% of the market in 2023 due to its ease of handling, storage, and blending across food, pharmaceutical, and feed applications.

Fish Protein Hydrolysate (FPH) Market Trends

Demand for sustainable proteins is driving significant shifts in the Fish Protein Hydrolysate market. In 2024, Asia‑Pacific accounted for over 55% of global volume consumption, propelled by expanding aquaculture in China, India and Japan. Year‑over‑year, the animal feed and pet food application segment-maintained dominance, consuming around 60% of total FPH output in 2022–2023. This trend aligns with industry findings that powdered FPH comprised 68% of the market in 2023–2024 due to its longer shelf life, easier handling and integration into dry blends. Technological innovation continues shaping the market landscape. Enzymatic hydrolysis—valued at 84% market share in 2023—enhanced production of high‑purity peptides, especially for functional food and pharmaceutical uses. Acid hydrolysis also reached approximately USD 28.7 million in output in 2024, highlighting its cost‑efficient appeal for bulk feed-grade FPH. Government policies have played a pivotal role: mandates for sustainable fish waste disposal in North America and Europe are fueling demand for value‑added uses of byproducts, with regulatory impetus pushing FPH applications in agriculture, animal feed and functional foods. A surge in collaborations between fisheries and manufacturers—such as new hydrolysis plants in India and piloted facilities in Europe—was reported in 2023–2024.

Industry‑wide trends show FPH increasingly entering functional food menus. Fish‑derived bioactive peptides—averaging 81–93% protein, with moisture content of 1–8% and fat under 5%—are being used to formulate sports nutrition and gut‑health products. In the U.S., pet‑food and aquafeed innovations drove FPH output to USD 50.7 million in 2024. Health‑oriented trends also pushed cosmetic and nutraceutical sectors to adopt FPH: North America and Europe registered USD 155 million collective value in 2024, supported by R&D focused on collagen‑type peptides. The sourcing trend is diversifying: beyond traditional anchovy, salmon and tuna, producers are exploring underutilized aquaculture species—tilapia, codfish and crustaceans—to expand supply and reduce cost. Powdered FPH composition now commonly features 81–93% protein, under 5% fat and moisture between 1–8%, making it suitable across food, feed, pharma and agriculture

Fish Protein Hydrolysate (FPH) Market Dynamics

DRIVER

"Rising demand for protein-rich, functional aquafeed and pet food ingredients."

Fish Protein Hydrolysate finds strong use in aquafeed: studies show inclusion of FPH peptides improves larval fish growth by 15–25%, improves feed conversion ratios, and boosts survival rates by 10–20%. In North America alone, over 60% of FPH production was directed toward animal nutrition in 2023. This demand is amplified by rising consumer interest in pets' health and sustainable protein sourcing: in 2022, pet food brands containing FPH reported a 12% volume increase year-over-year. Additionally, increasing incorporation of FPH in agriculture as a bio‑fertilizer and cryo‑protectant supports crop yields, with 20–30% improved seedling vigor reported in trials.

RESTRAINT

"Complex processing and high production costs."

The FPH manufacturing process is multi-stage, involving enzymatic or acid hydrolysis, followed by purification, filtration, drying, and sterilization. It requires specialized equipment, driving unit production costs up by over 30% compared to conventional fishmeal. Raw material price volatility—particularly for anchovy, salmon, and tuna—has increased FPH cost by around 15% between 2020 and 2023. Supply-chain challenges such as shelf-life issues (FPH moisture at 1–8%) also add 5–10% to handling and logistics costs.

OPPORTUNITY

"Growing adoption in nutraceuticals, cosmetics and agriculture."

FPH bioactive peptides possess immunomodulatory, antioxidant, antihypertensive and antimicrobial properties—leading to their integration into 15–20% of new functional food products launched between 2022–2024. Cosmetic applications have expanded: 25% of small-scale skincare brands now market FPH-based collagen boosters, with peptide concentrations of 81–93%, moisture at 1–8%, and fat below 5%. Agricultural use of FPH as bio-stimulants has shown to increase crop yield by 10–15% in pilot trials. Asian governments are offering subsidies (~USD 5 million in 2023) to develop FPH-based fertilizers and feed, enhancing raw‑material access and enabling small firms to enter the market.

CHALLENGE

"Supply constraints and regulatory hurdles."

FPH production depends on by-product fish stocks. Conservation and fishing restrictions have cut available biomass by up to 12% in key raw materials such as Atlantic salmon and tuna over 2021–2023. This has increased supplier competition and disrupted production cycles. Additionally, stringent safety, labeling, and allergen regulations—especially in the EU and North America—have delayed product approvals, with compliance costs up 18% since 2020. Small- and medium-scale producers report regulatory overhead accounting for 8–10% of operational budgets.

Fish Protein Hydrolysate (FPH) Market Segmentation

The Fish Protein Hydrolysate market is segmented by type and application, offering diverse use cases across industries. By type, the market is categorized into High Purity and Low Purity hydrolysates. By application, it includes Food, Feed Industry, Pharmaceuticals, Cosmetics, and Others. In 2023, over 60% of total FPH was consumed by the feed industry, while high-purity grades saw increased demand from nutraceuticals and functional food developers.

By Type

• High Purity: FPH, typically containing protein levels between 90–93%, low fat (<2%) and moisture content under 5%, is primarily used in pharmaceuticals, medical nutrition, and dietary supplements. This segment accounted for over 35% of market volume in 2023. The production of high purity FPH has grown significantly due to demand for bioactive peptides with antioxidant and antihypertensive properties. In Europe, over 120 metric tons of high purity FPH were used in sports nutrition and functional beverages in 2023. Moreover, enzymatic hydrolysis remains the preferred method for high-purity production, comprising 84% of the technology share.
• Low Purity: FPH, with protein content ranging from 60–80%, higher moisture levels (up to 8%), and fat content up to 5%, is widely used in animal feed, pet food, and agriculture. In 2023, this category represented 65% of total FPH output due to its cost-effectiveness and scalability. Asia-Pacific contributed to over 45% of low purity hydrolysate consumption, especially in aquaculture feed for tilapia and shrimp. India, Thailand, and Vietnam are key producers using low-value fish and by-products to produce low purity FPH at scale.

By Application

• Food: segment accounted for nearly 18% of global FPH usage. FPH is added to soups, sauces, protein drinks, and health bars for its umami flavor, solubility, and digestibility. The U.S. and Japan saw a 21% rise in new food product launches featuring FPH from 2022 to 2023.
• Feed Industry: The dominant application, feed-grade FPH was used in more than 60% of total market volume in 2023. Aquafeed applications for trout, salmon, and shrimp benefit from enhanced growth rates and reduced disease mortality when incorporating FPH at 3–5% inclusion levels.
• Pharmaceuticals: sector accounted for 9% of market share in 2023. High purity FPH peptides were used in supplements for muscle recovery, blood pressure management, and skin health. North America led in peptide-based clinical trials using FPH.
• Cosmetic: grade FPH represented 4–6% of the market in 2023. Collagen and elastin extracted from fish hydrolysate were formulated in serums and creams, with Europe producing over 220 tons of cosmetic FPH products in 2023.
• Others: applications include fertilizers, cryoprotectants, and microbial culture mediums. Agricultural FPH use grew by 12% between 2022 and 2023, especially in Latin America and Southeast Asia, where biofertilizers are in demand.

Fish Protein Hydrolysate (FPH) Market Regional Outlook

The global FPH landscape shows marked regional variation in production, consumption, and regulatory environments, with Asia-Pacific, North America, and Europe leading in market activity, while the Middle East & Africa displays emerging potential backed by aquaculture expansion and agricultural applications.

• North America

FPH production totaled approximately 70,000 metric tons, accounting for about 22% of global output. The U.S. alone generated close to USD 50.7 million in 2024 product sales, primarily through pet food and dietary supplement sectors. Mexico and Canada contributed another USD 14 million collectively in fisheries-based FPH products. High-purity FPH use grew by 28% year-over-year, especially in clinical nutrition and wellness beverage markets. Regional regulations mandating fish waste valorization have increased by-product utilization by 18% since 2021, supporting domestic industrial-scale hydrolysate plants.

• Europe

produced approximately 56,000 metric tons of FPH in 2023, representing around 18% of global output. Countries like Norway, Iceland, and Spain exported over 18,000 tons of FPH raw material to functional food manufacturers. Application in nutraceuticals rose by 32%, with over 120 metric tons of high-purity FPH used in sports supplements in 2023. Cosmetic-grade FPH accounted for 220 metric tons in serums and creams. Policy incentives for circular fisheries practices boosted by-product utilization by 15%, and R&D grants of over €4 million were awarded in 2023 to hydrolysate innovation projects.

• Asia‑Pacific

region dominated global FPH consumption with nearly 55% share in 2023, consuming more than 176,000 metric tons of FPH. China alone accounted for 45% of regional volume, using 85,000 tons in aquaculture feeds. India produced over 32,000 tons, and Japan used 14,000 tons in food and dietary applications. The region’s total market value reached around USD 185 million in 2023, largely driven by rising aquafeed demand and utilization of low-purity FPH (~65% of regional mix). Agricultural usage grew by 20% annually due to pilot biofertilizer programs in Southeast Asian nations.

• Middle East & Africa

produced about 18,000 metric tons of FPH, representing nearly 6% of global output. The UAE and Saudi Arabia imported over 7,000 tons of feed-grade FPH, primarily for livestock and aquaculture. Local processing volumes reached 11,000 tons, with 4,000 tons used in agriculture and cryoprotectant applications. Regional growth was supported by government funding—USD 2 million in subsidies—for aquaculture and agricultural innovation. Usage of FPH as a biofertilizer climbed by 15% from 2022 to 2023, mainly across countries like Egypt and South Africa.

List of Top Fish Protein Hydrolysate (FPH) Companies

• Green Earth Industries
• Neptunes Harvest
• Soc Pesquera Landes SA
• Bluewave Marine Ingredients
• TripleNine Group
• Symrise AG
• Hofseth BioCare ASA
• Omega Protein
• Natural Factors
• WEISHARDT

Omega Protein: remains one of the leading producers of fish protein hydrolysate in North America. In 2023, the company processed over 120,000 metric tons of fish annually, with more than 35% of its production volume allocated to FPH, particularly in pet food and aquaculture sectors.

Hofseth BioCare ASA: Based in Norway, Hofseth BioCare is a top-tier European manufacturer known for high-purity fish protein peptides. In 2023, the company produced over 7,200 metric tons of FPH, 85% of which was pharmaceutical or nutraceutical-grade.

Investment Analysis and Opportunities

Investments in the Fish Protein Hydrolysate (FPH) market have accelerated due to expanding applications in nutraceuticals, functional food, cosmetics, and animal feed. In 2023, over USD 120 million was invested globally in new processing facilities, R&D infrastructure, and expansion of enzymatic hydrolysis capabilities. Europe and Asia-Pacific collectively accounted for 70% of total new capacity installations, with Norway, India, and China leading in hydrolysate-based innovation centers. One key investment focus has been on green enzymatic processing technologies. Hofseth BioCare ASA, for example, announced a multi-million-euro investment in enhanced enzyme bioreactor systems to improve peptide purity for pharmaceutical use. Similarly, companies in India and Thailand invested in modular fish waste biorefineries capable of processing 20,000–40,000 metric tons of fish by-products annually, generating both hydrolysates and fish oil by co-extraction. These facilities are designed to reduce emissions by 30% compared to conventional methods and increase peptide yield by 12–18%. In North America, investments are largely concentrated in feed-grade FPH. Omega Protein expanded its U.S. facility to handle 230,000 metric tons of menhaden annually.

Additionally, U.S.-based startups in pet nutrition raised over USD 35 million in venture capital from 2022 to 2024 to formulate premium treats and supplements containing bioactive peptides from FPH. Functional food and sports nutrition manufacturers are increasingly allocating R&D budgets toward protein hydrolysates. In 2023, over 15% of new protein-based food product launches in Japan included FPH peptides as a key ingredient, especially due to their fast absorption and complete amino acid profile. Similarly, the European food-tech sector saw a 22% rise in clinical trials for FPH-based dietary products focused on cardiovascular, digestive, and skin health. The agricultural sector presents another promising area for capital deployment. Governments in Southeast Asia, including Indonesia and Vietnam, committed over USD 12 million in subsidies and grants during 2023–2024 to promote FPH-based biofertilizers and plant biostimulants. Trials showed 10–15% yield improvement in rice and leafy greens treated with FPH sprays or soil mixes. Cosmetic brands are also contributing to rising investment. European companies developing collagen-rich serums infused with FPH peptides experienced 28% sales growth from 2022 to 2023, prompting investments in clean-label marine protein ingredient sourcing and advanced peptide extraction. With global sustainability policies pushing for 100% fish utilization, investment in FPH represents a circular economy opportunity aligned with zero-waste goals. The combination of scalable processing, high-value by-products, and broad application potential makes the FPH market an attractive space for strategic capital infusion.

New Product Development

Product development in the Fish Protein Hydrolysate (FPH) market has intensified between 2023 and 2024, driven by the growing need for sustainable, high-performance proteins in human and animal nutrition. Technological advancements in enzymatic hydrolysis and improved peptide profiling have enabled manufacturers to launch novel products with higher bioavailability, tailored functionality, and extended shelf life. In 2023, Hofseth BioCare ASA launched ProGo® Bioactive Peptides, a pharmaceutical-grade FPH rich in essential amino acids and with a protein content of over 92%, designed for cardiovascular and metabolic health. Clinical evaluations showed that daily intake of ProGo led to a 12% reduction in systolic blood pressure and improved hemoglobin levels by 9.6% after 60 days of use. This marked a significant breakthrough in medical nutrition and opened the door for regulatory fast-tracking in several European markets. Meanwhile, in the functional food and beverage sector, Japanese and Korean manufacturers released FPH-based sports drinks and protein shots with rapid absorption claims. These beverages incorporate short-chain peptides (<1,500 Da) extracted via a multi-stage hydrolysis process and showed absorption rates 20–25% faster than conventional whey protein. In 2023, more than 45 new SKUs of peptide-rich ready-to-drink products were launched in the Asia-Pacific region alone.

In the pet food industry, U.S. brand expansion included FPH-enriched kibble, toppers, and dental chews aimed at gut health and immune support. Omega Protein introduced a high digestibility FPH powder for dogs and cats with over 80% crude protein, low ash, and fat content below 3%. Market penetration increased by 14% in premium pet nutrition retailers across the U.S. within six months of launch. In the cosmetics sector, WEISHARDT and Symrise AG focused on bioactive collagen peptides derived from marine fish. WEISHARDT introduced a new skin-care active ingredient in 2023 containing hydrolyzed fish collagen peptides, boasting 94% solubility and <5% molecular weight peptides. Clinical studies showed 25% increase in skin elasticity and 18% moisture retention in 8 weeks. Agricultural developments also saw innovation: Indian firms launched fish hydrolysate foliar sprays tailored for specific crops like rice and maize. These formulations offered 10–15% better nutrient uptake and contributed to faster germination rates. Across applications, companies are investing in microencapsulation, spray drying, and hybrid fermentation techniques to retain peptide stability and bioactivity. In 2024, new product pipelines featured over 60 FPH-derived formulations spanning dietary supplements, beverages, cosmetics, and fertilizers. This rapid diversification underscores the market’s shift toward high-value, science-backed hydrolysate products.

Five Recent Developments

• Hofseth BioCare ASA Launched ProGo® Clinical Peptide Line (2023): introduced a pharmaceutical-grade FPH formulation branded as ProGo®, containing over 92% protein and rich in essential amino acids. The product underwent clinical trials in Norway, showing a 12% reduction in blood pressure and improved hemoglobin by 9.6% within 60 days. This development positioned Hofseth’s FPH as a therapeutic alternative in cardiovascular and metabolic health markets.
• Omega Protein Expanded Processing Capacity in Virginia (2024): upgraded its Reedville, Virginia plant to increase annual menhaden processing to over 230,000 metric tons, a significant portion of which is used for FPH production. The upgrade allows for enzymatic hydrolysis lines capable of producing high-purity peptides for the pet and feed markets, supporting over 18% output growth from the previous year.
• WEISHARDT Released Marine Collagen Peptide Serum (2023): launched a new FPH-based skincare product under its cosmetics line containing fish-derived collagen peptides with <5 kDa molecular weight and over 94% solubility. Consumer trials reported a 25% increase in skin elasticity and 18% moisture improvement after 8 weeks of use, marking a breakthrough in cosmeceutical FPH application.
• Green Earth Industries Debuted Bio-Fertilizer Range for South Asia (2024): The company launched a specialized fish protein hydrolysate foliar spray tailored for rice and millet crops, with test results showing 15–17% yield improvements in India and Bangladesh. This product aligns with government-supported sustainability initiatives, helping the firm expand into over 1,200 hectares of commercial farmland.
• Bluewave Marine Ingredients Opened New Facility in Chile (2023): inaugurated a facility in Puerto Montt capable of producing 9,000 metric tons of fish hydrolysate annually. The plant integrates enzymatic processing with waste recovery systems, achieving 30% higher yield efficiency and supplying high-purity FPH for both animal feed and nutraceuticals in Latin America and Asia.

Report Coverage of Fish Protein Hydrolysate (FPH) Market

The Fish Protein Hydrolysate (FPH) market report delivers a comprehensive assessment of the global industry landscape, encompassing all key facets of production, processing technology, application trends, and regional dynamics. It thoroughly analyzes both high-purity and low-purity segments, detailing the functional, nutritional, and commercial properties that define their distinct industrial uses. The report captures detailed market metrics from 2020 through 2024 and projects forward-looking insights across major geographies including North America, Europe, Asia-Pacific, and the Middle East & Africa. It tracks consumption patterns of FPH across the animal feed, food & beverage, pharmaceutical, cosmetic, and agricultural sectors. For example, in 2023, over 60% of global FPH output was directed to aquafeed and pet nutrition, while pharmaceuticals and cosmetics contributed a combined 13%. Segment-wise analysis reveals shifting demand from low-purity blends toward bioactive high-purity peptides, which accounted for over 35% of the FPH market by volume in 2023. Technological coverage in the report emphasizes the dominance of enzymatic hydrolysis methods, which represented over 84% of production processes in 2023. It also evaluates innovations in multi-stage hydrolysis, membrane filtration, microencapsulation, and spray-drying techniques that enhance peptide retention, bioactivity, and shelf-life.

Additionally, the report reviews advances in processing byproducts from diverse fish sources including salmon, tuna, cod, anchovy, and underutilized species like tilapia. From a regional perspective, the report outlines how Asia-Pacific dominated global consumption with 55% market share in 2023, supported by aquaculture growth in China, India, and Vietnam. Europe is identified as a hub for cosmetic- and nutraceutical-grade FPH products, while North America remains a key player in pet nutrition. Emerging opportunities in the Middle East and Africa are discussed in the context of agricultural bio-stimulant use. The report also includes detailed company profiles, production capacities, and strategic initiatives of key players including Omega Protein, Hofseth BioCare ASA, TripleNine Group, Symrise AG, Bluewave Marine Ingredients, and WEISHARDT. For example, Omega Protein processed over 230,000 metric tons of menhaden annually as of 2024, a large portion directed toward enzymatically derived FPH. Investment activity, regulatory impact, and sustainability considerations are also addressed. With increased focus on full fish utilization and circular economy models, the report highlights how FPH is aligned with global zero-waste initiatives. It provides strategic recommendations for investors and manufacturers looking to enter or expand in this sector. The scope of the report spans value chain mapping, competitive benchmarking, raw material sourcing trends, processing cost structures, pricing trends, and SWOT analysis—making it a valuable resource for stakeholders across the food, feed, pharma, and agri-tech value chains.